Ian Dixon

13 Fuchsia St
Blackburn, VIC 3130, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Using an SMS to improve bowel cancer screening: the acceptability and feasibility of a multifaceted intervention.

Using an SMS to improve bowel cancer screening: the acceptability and feasibility of a multifaceted intervention.

Journal: Family practice
Published: December 20, 2024

SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.

SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.

Journal: Trials
Published: August 18, 2023

Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial.

Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial.

Journal: The British journal of general practice : the journal of the Royal College of General Practitioners
Published: May 16, 2023

First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing.

First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing.

Journal: Journal of extracellular vesicles
Published: October 12, 2022

The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.

The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.

Journal: Trials
Published: August 04, 2021

A small molecule inhibitor of PCSK9 that antagonizes LDL receptor binding via interaction with a cryptic PCSK9 binding groove.

A small molecule inhibitor of PCSK9 that antagonizes LDL receptor binding via interaction with a cryptic PCSK9 binding groove.

Journal: Bioorganic & medicinal chemistry
Published: August 23, 2019

Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice.

Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice.

Journal: Cytotherapy
Published: January 16, 2015

A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells.

A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells.

Journal: Cancer research
Published: August 16, 2013
Showing 1-8 of 8

Last Updated: 09/26/2026